Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...
A recent study has provided deeper insights into the microscopic mechanism behind heavy-ion cancer therapy, paving the way ...
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback